Literature DB >> 12217040

Synthesis and properties of degradable poly(urethane urea)s to be used for ligament reconstructions.

Katrin Gisselfält1, Bengt Edberg, Per Flodin.   

Abstract

In the present study we describe the synthesis, wet spinning, mechanical testing, and degradation of poly(urethane urea)s (PUURs) intended for clinical use in anterior cruciate ligament (ACL) reconstruction. The effects of soft segment chemical composition and molar mass and the kind of diamine chain extender on the material properties were investigated. It was found that the fibers made of PUUR with polycaprolactone diol (PCL530) as soft segment and MDI/1,3-DAP as hard segment (PCL530-3) have high tensile strength and high modulus and when degraded keep their tensile strength for the time demanded for the application. In conclusion, from a chemical and mechanical point of view PUUR fibers of PCL530-3, ARTELON, are suitable for designing a degradable ACL device.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12217040     DOI: 10.1021/bm025535u

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  20 in total

1.  Long-term results of a randomized study on anterior cruciate ligament reconstruction with or without a synthetic degradable augmentation device to support the autograft.

Authors:  Lars Peterson; Ulf Eklund; Björn Engström; Magnus Forssblad; Tönu Saartok; Anders Valentin
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-08-31       Impact factor: 4.342

2.  Biodegradable poly(ester urethane)urea elastomers with variable amino content for subsequent functionalization with phosphorylcholine.

Authors:  Jun Fang; Sang-Ho Ye; Venkat Shankarraman; Yixian Huang; Xiumei Mo; William R Wagner
Journal:  Acta Biomater       Date:  2014-08-14       Impact factor: 8.947

3.  The Artelon CMC spacer compared with tendon interposition arthroplasty.

Authors:  Anders Nilsson; Monica Wiig; Håkan Alnehill; Magnus Berggren; Sten Björnum; Mats Geijer; Philippe Kopylov; Christer Sollerman
Journal:  Acta Orthop       Date:  2010-04       Impact factor: 3.717

4.  Characterization of a new degradable polymer scaffold for regeneration of the dermis: In vitro and in vivo human studies.

Authors:  Fredrik Rm Huss; Erika Nyman; Carl-Johan Gustafson; Katrin Gisselfält; Elisabeth Liljensten; Gunnar Kratz
Journal:  Organogenesis       Date:  2008-07       Impact factor: 2.500

5.  Review of thumb carpometacarpal arthritis classification, treatment and outcomes.

Authors:  Joshua Gillis; Kevin Calder; Jason Williams
Journal:  Can J Plast Surg       Date:  2011

6.  Effect of the hard segment chemistry and structure on the thermal and mechanical properties of novel biomedical segmented poly(esterurethanes).

Authors:  P C Caracciolo; F Buffa; G A Abraham
Journal:  J Mater Sci Mater Med       Date:  2008-08-14       Impact factor: 3.896

7.  Elastomeric enriched biodegradable polyurethane sponges for critical bone defects: a successful case study reducing donor site morbidity.

Authors:  Catarina Lavrador; Ramiro Mascarenhas; Paulo Coelho; Cláudia Brites; Alfredo Pereira; Sylwester Gogolewski
Journal:  J Mater Sci Mater Med       Date:  2016-01-22       Impact factor: 3.896

8.  Electrospinning of novel biodegradable poly(ester urethane)s and poly(ester urethane urea)s for soft tissue-engineering applications.

Authors:  Pablo C Caracciolo; Vinoy Thomas; Yogesh K Vohra; Fabián Buffa; Gustavo A Abraham
Journal:  J Mater Sci Mater Med       Date:  2009-05-12       Impact factor: 3.896

9.  Synthesis and characterization of segmented poly(esterurethane urea) elastomers for bone tissue engineering.

Authors:  Katherine D Kavlock; Todd W Pechar; Jeffrey O Hollinger; Scott A Guelcher; Aaron S Goldstein
Journal:  Acta Biomater       Date:  2007-04-05       Impact factor: 8.947

10.  Hydrogel-elastomer composite biomaterials: 4. Experimental optimization of hydrogel-elastomer composite fibers for use as a wound dressing.

Authors:  Henry T Peng; Lucie Martineau; Andy Hung
Journal:  J Mater Sci Mater Med       Date:  2007-12-06       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.